Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

NCT06769126 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

900

Enrollment

NETWORK

Sponsor class

Conditions

Extensive Stage Lung Small Cell Carcinoma
Lung Small Cell Carcinoma, A Subtype
Lung Small Cell Carcinoma, I Subtype
Lung Small Cell Carcinoma, N Subtype
Lung Small Cell Carcinoma, P Subtype

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Ceralasertib
PROCEDURE: Computed Tomography
BIOLOGICAL: Durvalumab
DRUG: Etoposide
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Monalizumab
DRUG: Platinum Compound
PROCEDURE: Positron Emission Tomography
DRUG: Saruparib
RADIATION: Thoracic Radiation Therapy

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]